Structure Elucidation of Colibactin and Its DNA Cross-Links

Cited by (257)

Items 101–200 of 257

1. The specificity and structure of DNA cross-linking by the gut bacterial genotoxin colibactin
   Erik S. Carlson, Raphael Haslecker, Chiara Lecchi, Miguel A. Aguilar Ramos, Vyshnavi Vennelakanti, Linda Honaker, Alessia Stornetta, Estela S. Millán, Bruce A. Johnson, Heather J. Kulik et al. · 2025 · Science
2. Cancer Microbiology
   Daniel DiMaio, Brinda Emu, Andrew L. Goodman, Walther Mothes, Amy C. Justice · 2021 · JNCI Journal of the National Cancer Institute
3. Metabolic Interaction Between Host and the Gut Microbiota During High-Fat Diet-Induced Colorectal Cancer
   Chaeeun Lee, Seungrin Lee, Woongjae Yoo · 2024 · The Journal of Microbiology
4. Employing chemical synthesis to study the structure and function of colibactin, a “dark matter” metabolite
   Peyton C. Williams, Kevin M. Wernke, Alina Tirla, Seth B. Herzon · 2020 · Natural Product Reports
5. Cytotoxic Escherichia coli strains encoding colibactin, cytotoxic necrotizing factor, and cytolethal distending toxin colonize laboratory common marmosets (Callithrix jacchus)
   Colleen S. McCoy, Anthony J. Mannion, Yan Feng, Carolyn M. Madden, Stephen C. Artim, Gina G. Au, Mikayla Dolan, Jennifer L. Haupt, Monika A. Burns, Alexander Sheh et al. · 2021 · Scientific Reports
6. Cell free supernatants of Bifidobacterium adolescentis and Bifidobacterium longum suppress the tumor growth in colorectal cancer organoid model
   Min Jung Kim, Myoung-Hyun Song, Yosep Ji, Ji Won Park, Young-Kyoung Shin, Soon‐Chan Kim, Gihyeon Kim, Beomki Cho, Hansoo Park, Ja-Lok Ku et al. · 2025 · Scientific Reports
7. Comprehensive review on Fanconi anemia: insights into DNA interstrand cross-links, repair pathways, and associated tumors
   Chenyan Fang, Zhoujun Zhu, Jun Wei Cao, Jun Huang, Yipeng Xu · 2025 · Orphanet Journal of Rare Diseases
8. Identification and Mobilization of a Cryptic Antibiotic Biosynthesis Gene Locus from a Human-Pathogenic Nocardia Isolate
   Marion Hérisse, Keishi Ishida, Jessica L. Porter, Benjamin P. Howden, Christian Hertweck, Timothy Paul Stinear, Sacha J. Pidot · 2019 · ACS Chemical Biology
9. Dietary Patterns and Associated Microbiome Changes that Promote Oncogenesis
   Shakhzada Ibragimova, Revathy Ramachandran, Fahad R. Ali, Leonard Lipovich, Samuel B. Ho · 2021 · Frontiers in Cell and Developmental Biology
10. Two Polyketides Intertwined in Complex Regulation: Posttranscriptional CsrA-Mediated Control of Colibactin and Yersiniabactin Synthesis in Escherichia coli
    Nadine Rehm, Alexander Wallenstein, Marla Keizers, Stefan Homburg, Giuseppe Magistro, Camille V. Chagneau, Hanna Klimek, Olga Revelles, Emmanuelle Helloin, Johannes Putze et al. · 2022 · mBio
11. Microbial metabolites as modulators of host physiology
    Susan A. Joyce, David J. Clarke · 2024 · Advances in microbial physiology/Advances in Microbial Physiology
12. Evolution of Polymyxin Resistance Regulates Colibactin Production in Escherichia coli
    Patric W. Sadecki, Samantha J. Balboa, Lacey R. Lopez, Katarzyna M. Kedziora, Janelle C. Arthur, Leslie M. Hicks · 2021 · ACS Chemical Biology
13. Probing Microbiome Genotoxicity: A Stable Colibactin Provides Insight into Structure–Activity Relationships and Facilitates Mechanism of Action Studies
    Kevin M. Wernke, Alina Tirla, Mengzhao Xue, Yulia V. Surovtseva, Fabian Menges, Seth B. Herzon · 2021 · Journal of the American Chemical Society
14. Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells
    Sogari, Alberto, Rovera, Emanuele, Grasso, Gaia, Mariella, Elisa, Reilly, Nicole Megan, Lamba, Simona, Mauri, Gianluca, Durinikova, Erika, Vitiello, Pietro Paolo, Lorenzato, Annalisa et al. · 2024 · Cell Reports Medicine
15. Progress on targeted discovery of microbial natural products based on the predictions of both structure and activity
    Yuwei Zhang, Jian-Fa Zong, Yufeng Liu, Keyu Zhou, Haibo Shi, Wen‐Bing Yin, Ling Liu, Yihua Chen · 2025 · Natural Product Reports
16. Mechanistic dissection unmasks colibactin as a prevalent mutagenic driver of cancer
    Hilmar Berger, Thomas F. Meyer · 2021 · Cancer Cell
17. Tackling the Threat of Cancer Due to Pathobionts Producing Colibactin: Is Mesalamine the Magic Bullet?
    Min Tang-Fichaux, Priscilla Branchu, Jean‐Philippe Nougayrède, Éric Oswald · 2021 · Toxins
18. D-Serine reduces the expression of the cytopathic genotoxin colibactin
    Jennifer C. Hallam, Sofia Sandalli, Iris Floria, Natasha C. A. Turner, Min Tang-Fichaux, Éric Oswald, Nicky O’Boyle, Andrew J. Roe · 2023 · Microbial Cell
19. Newly Discovered Mechanisms of Antibiotic Self-Resistance with Multiple Enzymes Acting at Different Locations and Stages
    Xiaorong Chen, Hai‐Xue Pan, Gong‐Li Tang · 2022 · Antibiotics
20. Signaling Natural Products from Human Pathogenic Bacteria
    Zhijuan Hu, Wenjun Zhang · 2019 · ACS Infectious Diseases
21. Recent Advances in Discovery of Lead Structures from Microbial Natural Products: Genomics- and Metabolomics-Guided Acceleration
    Linda Sukmarini · 2021 · Molecules
22. Gut Microbiota in Colorectal Cancer: Associations, Mechanisms, and Clinical Approaches
    Cayetano Pleguezuelos‐Manzano, Jens Puschhof, Hans C. Clevers · 2021 · Annual Review of Cancer Biology
23. Repair of genomic interstrand crosslinks
    Marina A. Bellani, Althaf Shaik, Ishani Majumdar, Chen Ling, Michael M. Seidman · 2024 · DNA repair
24. Isolation, structure elucidation, total synthesis, and biosynthesis of dermazolium A, an antibacterial imidazolium metabolite of a vaginal bacterium Dermabacter vaginalis
    Hye Ryeong Kim, Jonghwan Kim, Jae Sik Yu, Bum Soo Lee, Ki Hyun Kim, Chung Sub Kim · 2023 · Archives of Pharmacal Research
25. Mass spectrometry-based metabolomics approaches to interrogate host–microbiome interactions in mammalian systems
    Atharva S. Kulkarni, Guilherme Carrara Moreira Paiva, Jiangpeiyun Jin, Jarrod A. Laro, Thilini Peramuna, Laura‐Isobel McCall, Neha Garg · 2025 · Natural Product Reports
26. Dysfunctional mucus structure in cystic fibrosis increases vulnerability to colibactin-mediated DNA adducts in the colon mucosa
    Amanda Mandarino Alves, Chiara Lecchi, Sharon Lopez, Alessia Stornetta, Prince P. Mathai, Peter W. Villalta, Satoshi Ishii, Emily P. Balskus, Silvia Balbo, Alexander Khoruts · 2024 · Gut Microbes
27. Elucidating the genotoxicity of Fusobacterium nucleatum-secreted mutagens in colorectal cancer carcinogenesis
    Wenye Xu, Yuchen Zhang, Dong-jiao Chen, Dan Huang, Yang Zhao, Wei Hu, Ling Lin, Yingzhi Liu, Shilan Wang, Judeng Zeng et al. · 2024 · Gut Pathogens
28. Colibactin-induced damage in bacteria is cell contact independent
    Emily Lowry, Amir Mitchell · 2024 · mBio
29. A bacterial mutational footprint in colorectal cancer genomes
    Axel Rosendahl Huber, Cayetano Pleguezuelos‐Manzano, Jens Puschhof · 2021 · British Journal of Cancer
30. Bacterial Toxins Are a Never-Ending Source of Surprises: From Natural Born Killers to Negotiators
    María López Chiloeches, Anna Bergonzini, Teresa Frisan · 2021 · Toxins
31. OUP accepted manuscript
    Noah P. Bradley, Lauren A. Washburn, Plamen P. Christov, Coran M. H. Watanabe, Brandt F. Eichman · 2020 · Nucleic Acids Research
32. Structural Basis for the Interactions of the Colibactin Resistance Gene Product ClbS with DNA
    Prabhanshu Tripathi, Steven D. Bruner · 2021 · Biochemistry
33. The Rapid Synthesis of Colibactin Warhead Model Compounds Using New Metal‐Free Photocatalytic Cyclopropanation Reactions Facilitates the Investigation of Biological Mechanisms
    Artemis Bosveli, Nefeli Griboura, Ioannis Kampouropoulos, Dimitris Kalaitzakis, Tamsyn Montagnon, Georgios E. Vassilikogiannakis · 2023 · Chemistry - A European Journal
34. Structural basis of the amidase ClbL central to the biosynthesis of the genotoxin colibactin
    Prabhanshu Tripathi, Jarrod J. Mousa, Naga Sandhya Guntaka, Steven D. Bruner · 2023 · Acta Crystallographica Section D Structural Biology
35. Intratumoral microorganisms in tumors of the digestive system
    Mengjuan Xuan, Xinyu Gu, Yingru Liu, Yang Li, Yi Li, Di Huang, Juan Li, Chen Xue · 2024 · Cell Communication and Signaling
36. The Fanconi anemia pathway repairs colibactin-induced DNA interstrand cross-links
    Maria Altshuller, He Xu, Elliot J. MacKrell, Kevin M. Wernke, Yougant Airan, Joel W. H. Wong, Selene Sellés‐Baiget, Ting‐Yu Wang, Tsui‐Fen Chou, Julien P. Duxin et al. · 2025 · Nature Communications
37. Microbial metabolites damage DNA
    Jens Puschhof, Cynthia L. Sears · 2022 · Science
38. Prevalence of genotoxic bacteria in men undergoing biopsy for prostate cancer
    John H. Lee, Brian L. Wickes, Jianmin Fu, Nohelli E. Brockman, Harshit Garg, Christian Jobin, Teresa L. Johnson‐Pais, Robin J. Leach, Zhao Lai, Michael Andre Liss · 2023 · The Prostate
39. Colorectal Organoids: Models, Imaging, Omics, Therapy, Immunology, and Ethics
    Martina Taglieri, Linda Di Gregorio, Serena Matis, Chiara Rosa Maria Uras, Massimo Ardy, Sara Casati, Monica Marchese, Alessandro Delli Poggi, Lizzia Raffaghello, Roberto Benelli · 2025 · Cells
40. Architecture of a PKS-NRPS hybrid megaenzyme involved in the biosynthesis of the genotoxin colibactin
    Sarah Bonhomme, Carlos Contreras‐Martel, Andréa Dessen, Pauline Machebœuf · 2023 · Structure
41. Stool pattern is associated with not only the prevalence of tumorigenic bacteria isolated from fecal matter but also plasma and fecal fatty acids in healthy Japanese adults
    Daiki Watanabe, Haruka Murakami, Harumi Ohno, Kumpei Tanisawa, Kana Konishi, Kikue Todoroki-Mori, Yuta Tsunematsu, Michio Sato, Yuji Ogata, Noriyuki Miyoshi et al. · 2021 · BMC Microbiology
42. Bacillamide D produced by Bacillus cereus from the mouse intestinal bacterial collection (miBC) is a potent cytotoxin in vitro
    Maximilian Hohmann, Valentina Brunner, Widya U. Johannes, Dominik Schum, Laura M. Carroll, Tianzhe Liu, Daisuke Sasaki, Johanna Bosch, Thomas Clavel, Stephan A. Sieber et al. · 2024 · Communications Biology
43. A host-centric view of the microbiota metabolome
    Takahiro Yamada, Noah W. Palm · 2025 · Immunity
44. Biodiversity and biogeography of the multi-kingdom cancer microbiome
    Anders B. Dohlman, Robin Mjelle, Henry M. Wood, Kevin Jiang, Alaina Shumate, Iris Lee, Gianmarco Piccinno, Garazi Serna, Abdul-Rakeem Yakubu, Paolo Giovanni Nuciforo et al. · 2026 · Cell
45. Mass spectrometry-based DNA adductomics
    Yuxiang Cui, Yinsheng Wang · 2022 · TrAC Trends in Analytical Chemistry
46. Biosynthesis of DNA-Alkylating Antitumor Natural Products
    Qiuyue Nie, Yu Hu, Xianfeng Hou, Gong‐Li Tang · 2022 · Molecules
47. Metabonomic Analysis of Metabolites Produced by Escherichia coli in Patients With and Without Sepsis
    Wang Yangyanqiu, Yin Jin, Xiaowei Ji, Man Huang, Bo Xie · 2022 · Infection and Drug Resistance
48. Colibactin DNA damage signature indicates causative role in colorectal cancer
    Paulina J. Dziubańska-Kusibab, Hilmar Berger, Federica Battistini, Britta A. M. Bouwman, Amina Iftekhar, Riku Katainen, Nicola Crosetto, Modesto Orozco, Lauri A. Aaltonen, Thomas F. Meyer · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
49. Discovery of a Two-Step Enzyme Cascade Converting Aspartate to Aminomalonate in Peptide Natural Product Biosynthesis
    Hye Won Kim, Sangwook Kang, Sihyeon Kim, Hyunbin Lee, Yegang Hur, Woon Ju Song, Dong‐Chan Oh, Seokhee Kim · 2025 · Journal of the American Chemical Society
50. Activity‐Based Protein Profiling Identifies Protein Disulfide‐Isomerases as Target Proteins of the Volatile Salinilactones
    Karoline Jerye, Helko Lüken, Anika Steffen, Christian Schlawis, Lothar Jänsch, Stefan Schulz, Mark Brönstrup · 2024 · Advanced Science
51. Cyclomodulins and Hemolysis in E. coli as Potential Low-Cost Non-Invasive Biomarkers for Colorectal Cancer Screening
    Kristýna Mezerová, Lubomír Starý, Pavel Zbořil, I Klementa, Martin Stašek, Petr Špička, Pavel Skalický, Vladislav Raclavský · 2021 · Life
52. Advancing the Biosynthetic and Chemical Understanding of the Carcinogenic Risk Factor Colibactin and Its Producers
    Yuichiro Hirayama, Michio Sato, Kenji Watanabe · 2022 · Biochemistry
53. Linkage and Stereochemistry Characters of Phenolic Antioxidant Product Formation
    Xican Li, Xiaojian Ouyang, Ban Chen, Shu‐Qin Liu, Jingyuan Zeng · 2023 · Journal of Agricultural and Food Chemistry
54. Colibactin leads to a bacteria-specific mutation pattern and self-inflicted DNA damage
    Emily Lowry, Yiqing Wang, Tal Dagan, Amir Mitchell · 2024 · Genome Research
55. Inverse Correlation between pks-Carrying Escherichia coli Abundance in Colorectal Cancer Liver Metastases and the Number of Organs Involved in Recurrence
    Yasuyuki Shigematsu, Rumiko Saito, Hiroaki Kanda, Yu Takahashi, Kengo Takeuchi, Shunji Takahashi, Kentaro Inamura · 2024 · Cancers
56. Synergistic action of specialized metabolites from divergent biosynthesis in the human oral microbiome
    McKenna Loop Yao, Nicholas A. Zill, Colin Charles Barber, Yongle Du, Peijun Lin, Rui Zhai, Eunice Yoon, Dunya Al Marzooqi, Wenjun Zhang · 2025 · Proceedings of the National Academy of Sciences
57. Chemical capture of diazo metabolites reveals biosynthetic hydrazone oxidation
    Katarina Pfeifer, Devon Van Cura, Kelvin J. Y. Wu, Emily P. Balskus · 2026 · Nature
58. Molecular messages in human microbiota
    Matthew T. Henke, Jon Clardy · 2019 · Science
59. Escherichia coli-Derived γ-Lactams and Structurally Related Metabolites Are Produced at the Intersection of Colibactin and Fatty Acid Biosynthesis
    Chung Sub Kim, Tayah Turocy, Gyuri Moon, Emilee E. Shine, Jason M. Crawford · 2021 · Organic Letters
60. Structure and function of prodrug-activating peptidases
    J. Velilla, Grace E. Kenney, Rachelle Gaudet · 2022 · Biochimie
61. A mutational signature that can be made by a bacterium arises in human colon cancer
    Ye Yang, Christian Jobin · 2020 · Nature
62. Erythromycin Stress Upregulates Antiangiogenic Metabolites in the Gut Bacterium Aneurinibacillus aneurinilyticus
    Young Jun Ha, Su Jung Hwang, Subin Hong, Jonghwan Kim, Minji Kim, Gyu Sung Lee, Seung Hwan Lee, Hyemin Kim, Bum Soo Lee, Hye In An et al. · 2025 · Journal of the American Chemical Society
63. L-serine promotes pro-carcinogenic effects of colibactin-producing E. coli
    A. Devaux, Romain Villéger, Gwenaëlle Roche, Binta Diémé, Michael Rodrigues, Charline Juban, Marie Lagrée, Nicolas Venisse, Cyril Jousse, Nicolas Barnich et al. · 2025 · Gut Microbes
64. RETRACTED: Understanding microbiota-driven oncogenesis: The role of metabolites in tumorigenesis
    Sadeeq Ullah, Chunyan Wu, Xiao Zou, Yangqing Zhong, Aftab Ahmad, Amin Ullah Jan, Yanguang Cong, Yong Chen, Lu Li · 2025 · iScience · Retracted
65. Drug delivery systems for enhanced tumour treatment by eliminating intra-tumoral bacteria
    Ziyi Liu, Yige Ma, Jin-Xin Ye, Guofeng Li, Xiaoxu Kang, Wensheng Xie, Xing Wang · 2023 · Journal of Materials Chemistry B
66. Microbiota mechanisms in cancer progression and therapy
    Xing Zhang, Kyong Tkhe Fam, Tingting Dai, Howard C. Hang · 2025 · Cell chemical biology
67. Structural study on human microbiome-derived polyketide synthases that assemble genotoxic colibactin
    Minjae Kim, Jinwoo Kim, Gyu Sung Lee, Paul Dominic B. Olinares, Yougant Airan, Jasmine L. Chow, Jongseok Park, Yujin Jeong, Jiho Park, Brian T. Chait et al. · 2025 · Structure
68. Distribution and virulence of Escherichia coli harboring cyclomodulins and supplementary virulence genes isolates from clinical and environmental samples
    Nora DeLira-Bustillos, Uriel Alberto Angulo Zamudio, Nidia Maribel León-Sicairos, Héctor M. Flores-Villaseñor, Jorge A. Velazquez-Roman, Gabriela Tapia-Pastrana, Francisco A. Martínez‐Villa, Rafael Velázquez‐Cruz, Jorge Salmerón, Samuel Canizales‐Quinteros et al. · 2024 · Microbial Pathogenesis
69. Screening method toward ClbP-specific inhibitors
    Tao Zhou, Takayuki Ando, Akihiro Kudo, Michio Sato, Noriyuki Miyoshi, Michihiro Mutoh, Hideki Ishikawa, Keiji Wakabayashi, Kenji Watanabe · 2023 · Genes and Environment
70. L-tryptophan and copper interactions linked to reduced colibactin genotoxicity in pks+ Escherichia coli
    Charlie F. Bayne, Magali Boutard, Tom Zaplana, Andrew C. Tolonen · 2024 · mSystems
71. Heterologous Expression of a Cryptic BGC from Bilophila sp. Provides Access to a Novel Family of Antibacterial Thiazoles
    Maximilian Hohmann, Denis Iliasov, Martin F. Larralde, Widya U. Johannes, Klaus‐Peter Janssen, Georg Zeller, Thorsten Mascher, Tobias A. M. Gulder · 2025 · ACS Synthetic Biology
72. Stimuli-responsive nanomaterials for eradicating intratumoral bacteria and augmenting tumor therapy efficiency: progress and perspectives
    Jianlin Wang, Zhenning Su, Xin Zhang, Siyu Wang, Xihua Chen, Xiangbo Xu, Bin He, Yufeng Zheng · 2025 · Biomaterials
73. Genome-scale CRISPR/Cas9 screening reveals the role of PSMD4 in colibactin-mediated cell cycle arrest
    Michael W. Dougherty, Ryan M. Hoffmann, Maria C. Hernandez, Yougant Airan, Raad Z. Gharaibeh, Seth B. Herzon, Ye Yang, Christian Jobin · 2025 · mSphere
74. pks+ E. coli adhesins—The fine line between good and evil
    Chi Chun Wong, Jun Yu · 2025 · Cell Host & Microbe
75. An overview of cancer and the human microbiome
    Soumendu Mahapatra, Smrutishree Mohanty, Rasmita Mishra, Punit Prasad · 2022 · Progress in molecular biology and translational science
76. Escherichia coli Nissle 1917 secondary metabolism: aryl polyene biosynthesis and phosphopantetheinyl transferase crosstalk
    Courtney V. Jones, Brianna Jarboe, Haley M. Majer, Amy T. Ma, Joris Beld · 2021 · Applied Microbiology and Biotechnology
77. Erratum for Wallenstein et al., “ClbR Is the Key Transcriptional Activator of Colibactin Gene Expression in Escherichia coli”
    Alexander Wallenstein, Nadine Rehm, Marina Brinkmann, Martina Selle, Nadège Bossuet‐Greif, Daniel Sauer, Boyke Bunk, Cathrin Spröer, Haleluya Tesfaye Wami, Stefan Homburg et al. · 2020 · mSphere
78. Progress in the application of the synergistic effects of nanomaterials and bacteria in tumor therapy
    Ran Yin, Haiying Jin, Jing Xia Yu, Lijun Shao, Xiaoli Yu · 2025 · Cancer Nanotechnology
79. Discovery of a Human Metabolite That Mimics the Bacterial Quorum-Sensing Autoinducer AI-2
    Emilee E. Shine, Julie S. Valastyan, Vanessa Y. Ying, Jonathan Z. Huang, Mohammad R. Seyedsayamdost, Bonnie L. Bassler · 2026 · Journal of the American Chemical Society
80. Polycarcin V induces DNA-damage response and enables the profiling of DNA-binding proteins
    Zongwei Yue, Fan Wu, Fusheng Guo, Jiyeong Park, Jin Wang, Liyun Zhang, Daohong Liao, Wenyang Li, Orlando D. Schärer, Xiaoguang Lei · 2022 · National Science Review
81. Synergistic effects of bloom helicase (BLM) inhibitor AO/854 with cisplatin in prostate cancer
    Xiaoyan Ma, Fu Tian, Yuanpin Xiao, Meng-Qiu Huang, Dan-Dan Song, Xinli Chen, Houqiang Xu · 2024 · Scientific Reports
82. Colibactin Exerts Androgen-dependent and -independent Effects on Prostate Cancer
    Raag Agrawal, Sarah M. Al-Hiyari, Rupert Hugh-White, Robert Hromas, Yash Patel, Elizabeth A. Williamson, Mohammed Faizal Eeman Mootor, Alfredo Gonzalez, Jianmin Fu, Roni Haas et al. · 2024 · European Urology Oncology
83. Overcoming stochastic variations in culture variables to quantify and compare growth curve data
    Christopher W. Sausen, Matthew L. Bochman · 2021 · BioEssays
84. Which bacterial toxins are worthy of validation as markers in colorectal cancer screening? A critical review
    Kristýna Mezerová, Vladislav Raclavský, Lubomír Starý · 2021 · Biomedical Papers
85. The mysteries of macrocyclic colibactins
    Erik S. Carlson, Emily P. Balskus · 2019 · Nature Chemistry
86. Colibactin-induced genotoxicity and colorectal cancer exacerbation critically depends on adhesin-mediated epithelial binding
    Maude Jans, Magdalena Kolata, Gillian Blancke, Maarten Ciers, Anders B. Dohlman, Takato Kusakabe, Mozes Sze, Alexandra Thiran, Geert Berx, Sabine Tejpar et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
87. Polyketide synthase positive Escherichia coli one‐time measurement in stool is not informative of colorectal cancer risk in a screening setting
    Willemijn de Klaver, Meike de Wit, Anne S. Bolijn, Marianne Tijssen, Pien Delis‐van Diemen, Margriet Lemmens, Manon C.W. Spaander, Evelien Dekker, Monique Esther van Leerdam, Veerle M.H. Coupé et al. · 2024 · The Journal of Pathology
88. Combatting virulent gut bacteria by inhibiting the biosynthesis of a two-component lanthipeptide toxin
    Ryan Moreira, Bidisha Chakraborty, Yi Yang, Chandrashekhar Padhi, Michael S. Gilmore, Satish K. Nair, Wilfred A. van der Donk · 2025 · Nature Communications
89. Mutanobactin D from the Human Microbiome: Chemistry, Biology, and Molecular Dynamics Studies
    Patricia Brandl, Lukas Lüthy, Felix Pultar, Moritz E. Hansen, Nicola Jelmini, Justin Faris, Samuel O. Yasmin, Anna Sophia Kamenik, René Arnold, Marc‐Olivier Ebert et al. · 2025 · Journal of the American Chemical Society
90. Microbiome–Genome Crosstalk in Colorectal Cancer: Colibactin Signatures and Fusobacterium nucleatum in Epidemiology, Driver Selection, and Translation
    Sungwon Jung · 2026 · International Journal of Molecular Sciences
91. Strain Diversity in the Human Microbiome: Personal Variation, Pathobionts, Therapeutics, and Methodological Challenges
    Hyunjoon Park, Jung Soo Kim, Dong Joon Kim, Ki Tae Suk · 2026 · Microorganisms
92. Chemiluminescent Probes Allow for the Rapid Identification of Colibactin-Producing Bacteria
    Miguel A. Aguilar Ramos, Sara Gutkin, Maya David, Doron Shabat, Emily P. Balskus · 2026 · JACS Au
93. Gut microbiota in health and disease
    Y N Li, Xueyan Xiao, Xin Jiang, Xinyi Li, W WANG, Rong Lin · 2026 · Molecular Biomedicine
94. Metaproteomics of human microbiota: Progress and key challenges for precision medicine
    Yu‐Qi Feng, Dongbo Liu, Yongheng Chen, Wei Zhang, Yijing He · 2025 · Process Biochemistry
95. Vat-Mediated Mucus Penetration Enables Genotoxic Activity of pks+ Escherichia coli
    Héloïse Chat, Léa Girondier, Guillaume Dalmasso, Caroline Vachias, Laurent Guillouard, Virginie Bonnin, Devon W. Kavanaugh, Aurélien Birer, Mathilde Bonnet, Nicolas Barnich et al. · 2025 · International Journal of Molecular Sciences
96. Natural products influence bacteriophage infectivity
    Zhiyu Zang, Joseph P. Gerdt · 2025 · Natural Product Reports
97. Synthesis of Colibactin Pyrrolidono[3,4-d]pyridones via Regioselective C(sp3)–H Activation
    Agron Ilazi, Bin Huang, Valery de Almeida Campos, Karl Gademann · 2020 · Organic Letters
98. Total synthesis of (±)-3-thiaglutamate
    Hao Chen, Sohjeong Kim, Chi P. Ting · 2024 · Tetrahedron Letters
99. The covalent reactivity of functionalized 5-hydroxy-butyrolactams is the basis for targeting of fatty acid binding protein 5 (FABP5) by the neurotrophic agent MT-21
    Esben B. Svenningsen, Rasmus N. Ottosen, Katrine Bruun Jørgensen, Marija Nišavić, Camilla K. Larsen, Bente K. Hansen, Yong Wang, Kresten Lindorff‐Larsen, Thomas Tørring, Stephan M. Hacker et al. · 2022 · RSC Chemical Biology
100. The gut bacterial natural product colibactin triggers induction of latent viruses in diverse bacteria
     Justin E. Silpe, Joel W. H. Wong, Siân V. Owen, Michael Baym, Emily P. Balskus · 2021 · bioRxiv (Cold Spring Harbor Laboratory)